United Kingdom· GB-APID-8145111000001103
Karvol Decongestant capsules
A chlorobutanol product containing chlorobutanol, registered in United Kingdom by Reckitt Benckiser Healthcare (UK) Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Chlorobutanol
- Manufacturer
- Reckitt Benckiser Healthcare (UK) Ltd
- Country
- United Kingdom (GB)
- ATC code
- A04AD04
- ATC class
- Chlorobutanol
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 3
- gtin5000167008173
- gtin5000158101258
- gtin5000158101265
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorobutanol in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0657592f-8613-4765-bdea-c41ef4e73f7b GET /v1/drugs/0657592f-8613-4765-bdea-c41ef4e73f7b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "8145111000001103",
"desc": "Karvol Decongestant capsules (Reckitt Benckiser Healthcare (UK) Ltd)",
"form": "Inhalation vapour capsule",
"vpid": "8147411000001102",
"source": "dmd",
"vtm_id": null,
"strength": "2.25 mg",
"substance": null,
"ingredient": "Chlorobutanol",
"supplier_code": "2084201000001101"
}See everything about chlorobutanol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.